• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Search 
    •   QMRO Home
    • Search
    •   QMRO Home
    • Search
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Discover

    Author
    Baumbach, A (32)
    Windecker, S (11)Byrne, RA (7)Capodanno, D (5)Haude, M (5)Gilard, M (4)James, S (4)Lansky, A (4)Onuma, Y (4)Price, S (4)... View MoreSubject
    Humans (32)
    Percutaneous Coronary Intervention (16)Female (12)Male (12)Middle Aged (12)Treatment Outcome (12)Aged (10)Time Factors (9)Drug-Eluting Stents (8)ST Elevation Myocardial Infarction (8)... View MoreDate Issued2022 (1)2021 (2)2020 (5)2019 (3)2018 (11)2017 (7)2016 (1)2015 (2)
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Search

    Show Advanced FiltersHide Advanced Filters

    Filters

    Use filters to refine the search results.

    Now showing items 1-10 of 32

    • Sort Options:
    • Relevance
    • Title Asc
    • Title Desc
    • Issue Date Asc
    • Issue Date Desc
    • Results Per Page:
    • 5
    • 10
    • 20
    • 40
    • 60
    • 80
    • 100
    Thumbnail

    Incidence, Predictors, and Clinical Impact of Early Prasugrel Cessation in Patients With ST-Elevation Myocardial Infarction. 

    Koskinas, KC; Zanchin, T; Klingenberg, R; Gencer, B; Temperli, F; Baumbach, A; Roffi, M; Moschovitis, A; Muller, O; Tüller, D;... (2018-04-13)
    BACKGROUND: Early withdrawal of recommended antiplatelet treatment with clopidogrel adversely affects prognosis following percutaneous coronary interventions. Optimal antiplatelet treatment is essential following ST-segment ...
    Thumbnail

    Defining device success for percutaneous coronary intervention trials: a position statement from the European Association of Percutaneous Cardiovascular Interventions of the European Society of Cardiology. 

    Chang, CC; Kogame, N; Onuma, Y; Byrne, RA; Capodanno, D; Windecker, S; Morel, M-A; Cutlip, DE; Krucoff, MW; Stone, GW;... (2020-01-17)
    Percutaneous coronary intervention with implantation of drug-eluting stents has become the most commonly performed revascularisation procedure in patients with symptomatic coronary artery disease. Continuous iterations of ...
    Thumbnail

    Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary. 

    Byrne, RA; Stefanini, GG; Capodanno, D; Onuma, Y; Baumbach, A; Escaned, J; Haude, M; James, S; Joner, M; Jüni, P;... (2018-05-07)
    A previous Task Force of the European Society of Cardiology (ESC) and European Association of Percutaneous Cardiovascular Interventions (EAPCI) provided a report on recommendations for the non-clinical and clinical evaluation ...
    Thumbnail

    Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative. 

    Lansky, AJ; Messé, SR; Brickman, AM; Dwyer, M; van der Worp, HB; Lazar, RM; Pietras, CG; Abrams, KJ; McFadden, E; Petersen, NH;... (2017-02)
    Surgical and catheter-based cardiovascular procedures and adjunctive pharmacology have an inherent risk of neurological complications. The current diversity of neurological endpoint definitions and ascertainment methods ...
    Thumbnail

    Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). 

    Capodanno, D; Petronio, AS; Prendergast, B; Eltchaninoff, H; Vahanian, A; Modine, T; Lancellotti, P; Sondergaard, L; Ludman, PF; Tamburino, C;... (2017-09-01)
    Thumbnail

    Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary. 

    Byrne, RA; Stefanini, GG; Capodanno, D; Onuma, Y; Baumbach, A; Escaned, J; Haude, M; James, S; Joner, M; Jüni, P;... (2018-01-20)
    A previous Task Force of the European Society of Cardiology (ESC) and European Association of Percutaneous Cardiovascular Interventions (EAPCI) provided a report on recommendations for the non-clinical and clinical evaluation ...
    Thumbnail

    EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic. 

    Chieffo, A; Stefanini, GG; Price, S; Barbato, E; Tarantini, G; Karam, N; Moreno, R; Buchanan, GL; Gilard, M; Halvorsen, S;... (2020-05-14)
    The coronavirus disease 2019 (COVID-19) pandemic poses an unprecedented challenge to healthcare worldwide. The infection can be life threatening and require intensive care treatment. The transmission of the disease poses ...
    Thumbnail

    EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic. 

    Chieffo, A; Stefanini, GG; Price, S; Barbato, E; Tarantini, G; Karam, N; Moreno, R; Buchanan, GL; Gilard, M; Halvorsen, S;... (2020-06-25)
    The coronavirus disease 2019 (COVID-19) pandemic poses an unprecedented challenge to healthcare worldwide. The infection can be life threatening and require intensive care treatment. The transmission of the disease poses ...
    Thumbnail

    One-year efficacy and safety of everolimus-eluting bioresorbable scaffolds in the setting of acute myocardial infarction. 

    Kim, Y; Bae, S; Jeong, MH; Ahn, Y; Kim, CJ; Cho, MC; Baumbach, A; Gogas, BD; King, SB; Other Korea Acute Myocardial Infarction Registry Investigators (Public Library of Science, 2020-07-09)
    BACKGROUND AND OBJECTIVES: This study sought to compare clinical outcomes between bioresorbable scaffolds (BRS) and durable polymer everolimus-eluting metallic stents (DP-EES) in patients with acute myocardial infarction ...
    Thumbnail

    Self-expandable sirolimus-eluting stents compared to second-generation drug-eluting stents for the treatment of the left main: A propensity score analysis from the SPARTA and the FAILS-2 registries. 

    Montefusco, A; D'Ascenzo, F; Gili, S; Smolka, G; Chieffo, A; Baumbach, A; Escaned, J; Sganzerla, P; Tomassini, F; Secco, GG;... (2019-02-01)
    OBJECTIVES: To compare the effectiveness and safety of self-expandable, sirolimus-eluting Stentys stents (SES) and second-generation drug-eluting stents (DES-II) for the treatment of the unprotected left main (ULM). ...
    • 1
    • 2
    • 3
    • 4
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.